| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
B Signaling Pathways
From the Department of Pharmacology (R.M., D.A.C., J.F., E.S.F, M.M.C., J.B.C), Universidade Federal de Santa Catarina, Brazil; Department of Pharmacology (M.C.W.A) and Department of Biophysics (M.A.S.M., J.B.P.), Universidade Federal de São Paulo, Brazil; Max Delbrück Centre for Molecular Medicine (D.A.C., M.B.), Berlin-Buch, Germany.
Correspondence to João B. Calixto, Department of Pharmacology, Centre of Biological Sciences, Universidade Federal de Santa Catarina, Rua Ferreira Lima, 82, 88015-420, Florianópolis, SC, Brazil. E-mail calixto{at}farmaco.ufsc.br or calixto3{at}terra.com.br
The bradykinin B1 receptor (B1R) is normally absent under physiological conditions, but is highly inducible during inflammatory conditions or following tissue damage. The present study attempted to determine some of the mechanisms underlying B1R upregulation following tissue injury in rat portal vein. Damage induced by tissue isolation and in vitro incubation caused a significant and time-dependent increase in des-Arg9bradykinin (des-Arg9BK) responsiveness that paralleled the B1R mRNA expression, as confirmed by real-time quantitative PCR. In vitro incubation of rat portal vein also induced the activation of some members of the mitogen activated protein kinase (MAPK) family, namely, extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 MAPK, an effect accompanied by degradation of the inhibitory protein I
B
and translocation of nuclear transcription factor-
B (NF-
B) to the nucleus. The blockade of p38 MAPK, JNK or NF-
B, but not ERK pathways with selective inhibitors, resulted in a significant reduction of the upregulated contractile response caused by the selective B1R agonist des-Arg9BK, and largely prevented the induction of B1R mRNA expression in the rat portal vein. Together, these results demonstrate that in vitro tissue damage induces activation of several intracellular signaling pathways that have a key role in the control of B1R expression. B1R could exert a pivotal role in the development of the cardiovascular response associated with vascular damage.
Key Words: receptor, bradykinin B1tissue damage mitogen-activated protein kinases portal vein rats
This article has been cited by other articles:
![]() |
M. A. Mori, R. C. Araujo, F. C.G. Reis, D. G. Sgai, R. G. Fonseca, C. C. Barros, V. F. Merino, M. Passadore, A. M. Barbosa, B. Ferrari, et al. Kinin B1 Receptor Deficiency Leads to Leptin Hypersensitivity and Resistance to Obesity Diabetes, June 1, 2008; 57(6): 1491 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Moreau, M.-T. Bawolak, G. Morissette, A. Adam, and F. Marceau Role of Nuclear Factor-{kappa}B and Protein Kinase C Signaling in the Expression of the Kinin B1 Receptor in Human Vascular Smooth Muscle Cells Mol. Pharmacol., March 1, 2007; 71(3): 949 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Pelorosso, A. V. Halperin, A. M. Palma, W. Nowak, A. E. Errasti, and R. P. Rothlin Neutral Endopeptidase Up-Regulation in Isolated Human Umbilical Artery: Involvement in Desensitization of Bradykinin-Induced Vasoconstrictor Effects J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 713 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Sayah, R. Medeiros, E. S. Fernandes, M. M. Campos, and J. B. Calixto Mechanisms Underlying Lipopolysaccharide-Induced Kinin B1 Receptor Up-Regulation in the Pig Iris Sphincter in Vitro Mol. Pharmacol., May 1, 2006; 69(5): 1701 - 1708. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |